This week we took a look at the controversial contraception debate going on in Washington, as well as the FDA’s recent safety alert regarding statins. Also this week:
- A look at how to reduce Medicare reimbursement costs
- The FDA’s new tobacco labels take another hit from the courts
- The future of healthcare: mHealth technology?
- Inexpensive compliance programs are doable!
- The future in health identification numbers
